TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Study satisfaction and acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of thrombo-embolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) Leading to Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator Assessment Questionnaire (IAQ) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Global Impression - Severity of Illness (CGI-S) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of Energy in Kilocalories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Protein intake in grams
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Fat intake in grams
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in carbohydrate intake in grams
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in micronutrients intake in micrograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of type 1 hypersensitivity reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of type 4 hypersensitivity reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Microbiome alpha-diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome beta-diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral and gastric H. pylori infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Oral and gastric H. pylori eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Overall Best-Worst Scaling Task Index Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Communication outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intuitive eating scale (IES-2)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Power of food scale (PFS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Food Craving Questionnaire (FCQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pittsburg Sleep Quality Scale (PUKI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum peak concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measure of body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood test to check cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of an organ/space surgical site infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Children's interactional behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Warning signs of neurodevelopmental disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events related to 89Zr-DFO-REGN3767 administration
Endpoint domain: Adverse events/effects
Primary endpoint: Pathology of endometrial lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Self-report of parental stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-report perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in VTI cutoff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intubation Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Treatment Expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in intention to seek treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: NIRS delta_recovery amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIRS reoxygenation kinetics: tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIRS reoxygenation kinetics: Peak reoxygenation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events and serious adverse events rate
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of clinical significant changes in laboratory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of abnormal neurological physical examination results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of imaging changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural control assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Modified Progression-Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: IGA score for patients with melasma or acne induced post-inflammatory hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: modified Melasma Area and Severity Index (mMASI) for patients with melasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Post-Acne Hyperpigmentation Index (PAHPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Ga-68 MAA radiotracer activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-Agility Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardized uptake value (SUV) for BBPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal motility outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ocular surface disease index questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Non-invasive tear film break-up time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer I test without anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention attendance log
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Encorafenib Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Encorafenib AUClast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Encorafenib AUC(0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac Rate (heart rate/pulse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardio-Vascular mortality
Endpoint domain: Mortality/survival
Primary endpoint: Number of Periods of Carbon monoxide (CO) Instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Spent in Periods of CO Instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Titers of Hepatitis B virus surface antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Q angle assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Treatment-emergent laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Change of left ventricular global longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of participants completing the assigned mindfulness exercises
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alanine transaminase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on the Rivermead Post Concussion Symptoms Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agreement in detecting central visual field defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Enteric Microbiome abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enteric Microbiome diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative improvement in acneiform eruptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: therapeutic choice for bladder cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neurogenic Bowel Dysfunction (NBD) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Position stability of Clareon and Tecnis 1 IOL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of residual bacterial light spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Numbers of Re-debridement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Freedom from Distant Metastases
Endpoint domain: Mortality/survival
Primary endpoint: Visual Analogue Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: salivary amylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of life status
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in distance from Six Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean Glutathione (GSH)/ oxidized GSH (GSSG) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage neutralizing antibody levels at 2m
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: WHO International units/ml neutralizing antibody levels at 2m
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titres (GMT) neutralizing antibody levels at 2m
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in laryngeal view
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free amino acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gut hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Markers related to general metabolic health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude towards dental care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of subjects achieving disease response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of SNPs associated with breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cerebral autoregulation index (pressure reactivity index PRx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral autoregulation index (mean flow index Mx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Optimal arterial blood pressure value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Comparison of transfemoral approach and transradial approach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinically-driven target lesion re-intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory muscle activity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of mechanical restraints
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in effectiveness in raising FL level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of measurement of capillary whole blood potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of study enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of retention of study participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants adhering to study protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of intervention-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to ambulation goal
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Corticotropic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Caregiver Report of Early Development Index (CREDI Instrument)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Early Childhood Development Indicators (ECDI Instrument)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Veterans consenting to study participation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of treatment protocol and scheduled outcome assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of central subfield thickness (CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amelioration of functions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fibroid recurrence on ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: plasma maximum concentration (Cmax) of encapsulated doxorubicin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under Plasma concentration-time curves of encapsulated doxorubicin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma maximum concentration (Cmax) of unencapsulated doxorubicin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under Plasma concentration-time curves of unencapsulated doxorubicin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional capacity: Barthel Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional capacity: Lawton Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional capacity: Short Physical Performance Battery test (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional capacity: Strength (Handgrip)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cognitive function by the Índice de Incapacidad psíquica de la Cruz Roja (IPCR)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in pigmentation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in wrinkle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Social and emotional development
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Ankle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ankle Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somatosensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity of dMMR status determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of dMMR status determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of secondary fragility hip fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cumulative Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Peak time in plasma (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's blood hemoglobin concentration level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: children's Anthropometric deficits; Wasting, stunting and underweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's Episode of Diarrheal, cough and fever Morbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Wisconsin gait scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Accuracy of SpO2 measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success at 12 months after the procedure for DMR Cohort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from all-cause mortality or hospitalization for heart failure events at 12 months for FMR Cohort
Endpoint domain: Mortality/survival
Primary endpoint: Post-bleaching hypersensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: Shade stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMS induced Brain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Skin Dehiscence Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Partial Skin Necrosis Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: CSF Leak Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Local Infection Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Amyloid positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Imaging capability of 18F-RO948, 18F-MK6240 and 18F-GTP1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between imaging capability and amyloid positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postreperfusion syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Change in perceived Stress scale of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of iCPR Tool usefulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in number of Acute Respiratory Infection encounters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intraoral viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: INFANIB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in microbial diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in efficacy of fat grafting technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient satisfaction of fat grafting technique
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ascorbic Acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Classification of diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Frequency of adverse events associated with MVA-MERS-S_DF-1
Endpoint domain: Adverse events/effects
Primary endpoint: Characteristics of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Verbal response accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Fugl-Meyer scores for Upper Extremity-Motor Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinically significant changes in physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Connor-Davidson Resilience Scale 10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Lurz-Wilde pediatric frailty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: needle-to-wire time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Oral Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: AUCt of tegoprazan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes